CoChat

How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?

Open access
Maningat, Patricia, Gordon, Bruce R., Breslow, Jan L. · 2013 · Current Atherosclerosis Reports

The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.

Abstract

Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical trials will only be replicated in real-life if patients adhere to the prescribed treatment regimen. But, about half of patients discontinue statin therapy within the first year, and adherence decreases with time. Patient, physician and healthcare system-related factors play a role in this problem. Recent studies have focused more on the patients' perspectives on non-adherence. Adverse events are cited as the most common cause of statin discontinuation; thus, the healthcare provider must be willing to ally and dialogue with patients to address concerns and assess the risks and benefits of continued statin therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11883-012-0291-7

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Research works printed but not linked: 2

  1. Stagnitti M. Trends in Statins Utilization and Expenditures for the U.S. Civilian Noninstitutionalized Population, 2000 and 2005. Statistical Brief #205. In. Edited by Quality AfHRa, vol. 2011. Rockville, MD; 2008.
  2. Golomb BA, Yang E, Denenberg J, Criqui MH. Statin-associated adverse effects. Circulation. 2003;107:e7028–9.

Cited by

See all 208

Metadata

Authors
Maningat, P., Gordon, B. R., & Breslow, J. L.
Affiliations
  • Rockefeller University (US)
  • The Rogosin Institute (US)
Corresponding author
Breslow, Jan L.
Venue
Current Atherosclerosis Reports
Published
2012-12-09
Volume
15
Issue
1
Pages
291-291
ISSN
  • 1523-3804 (ISSN-L)
  • 1534-6242
OpenAlex
W2053873360
Cited by
208
References
83
Citations by year
2026: 7 · 2025: 13 · 2024: 11 · 2023: 15 · 2022: 13 · 2021: 31 · 2020: 14 · 2019: 18 · 2018: 25 · 2017: 20 · 2016: 14 · 2015: 9 · 2014: 10 · 2013: 6
FWCI
1.05
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Atherosclerosis Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000043)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Keywords
statins, medication adherence, treatment discontinuation, adverse drug reactions, patient perspectives, LDL cholesterol lowering, cardiovascular risk reduction, patient-physician communication, long-term treatment
MeSH terms
Cardiovascular Diseases, Humans, Cholesterol, LDL, Patient Compliance, Primary Prevention, Time Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy? https://app.cochat.ai/papers/10.1007/s11883-012-0291-7
The paper
Maningat, P., Gordon, B. R., & Breslow, J. L. (2013). How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy? Current Atherosclerosis Reports. https://doi.org/10.1007/s11883-012-0291-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.